Cargando…

Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting

BACKGROUND: Current day malaria cases and deaths are indicative of a lack of access to both methods of prevention, diagnosis, and treatment; an important determinant of treatment efficacy is adherence. This study is a follow up to the baseline study of adherence to artemether-lumefantrine (AL) carri...

Descripción completa

Detalles Bibliográficos
Autores principales: Gore-Langton, Georgia R, Alenwi, Nfornuh, Mungai, James, Erupe, Nahashon I, Eves, Katie, Kimwana, Francis Njoroge, Soti, David, Akhwale, Willis, Hassan, Farah A, Juma, Elizabeth, Allan, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405916/
https://www.ncbi.nlm.nih.gov/pubmed/25888895
http://dx.doi.org/10.1186/s12936-015-0645-z
_version_ 1782367684151738368
author Gore-Langton, Georgia R
Alenwi, Nfornuh
Mungai, James
Erupe, Nahashon I
Eves, Katie
Kimwana, Francis Njoroge
Soti, David
Akhwale, Willis
Hassan, Farah A
Juma, Elizabeth
Allan, Richard
author_facet Gore-Langton, Georgia R
Alenwi, Nfornuh
Mungai, James
Erupe, Nahashon I
Eves, Katie
Kimwana, Francis Njoroge
Soti, David
Akhwale, Willis
Hassan, Farah A
Juma, Elizabeth
Allan, Richard
author_sort Gore-Langton, Georgia R
collection PubMed
description BACKGROUND: Current day malaria cases and deaths are indicative of a lack of access to both methods of prevention, diagnosis, and treatment; an important determinant of treatment efficacy is adherence. This study is a follow up to the baseline study of adherence to artemether-lumefantrine (AL) carried out in Garissa District in 2010. The study presented evaluates any changes in adherence levels which may have occurred in the area during this period and after nearly three years of sustained use of ACT across the public health sector. METHODS: The study was carried out in Garissa County in the North Eastern Province of Kenya and included patients fitting the suspected malaria case definition and having been prescribed AL, regardless of confirmatory diagnosis. A questionnaire assessed the intake of AL via both self-reporting by the participant and observation of blister packs by the interviewer. On separate occasions exit interviews with patients and observations of prescribers were also carried out. RESULTS: Of the 218 participants enrolled, 195 were successfully followed up. 60% of participants were found to be adherent to the three-day AL regimen, this is 4.7% lower than the proportion of participants adherent in 2010; the result of a two-sided z-test was not significant (p = 0.23). The odds of the patient being adherent to AL increased by 65% with each additional correct statement regarding how to take AL that a patient could recall (between zero and four statements), this was the only variable significantly associated with patient adherence (p = 0.01). CONCLUSION: Sustaining the ACT adherence rates at the 2010 levels, through 2.5 years of insecurity in the study area is an achievement and suggests that if security can be improved barriers to improving health service quality and patient adherence to AL would be removed. This study, by looking specifically at anti-malarial adherence over a prolonged period and in a setting of severe conflict, provides a valuable and rare insight in to the challenges and barriers to ACT adherence in such settings.
format Online
Article
Text
id pubmed-4405916
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44059162015-04-23 Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting Gore-Langton, Georgia R Alenwi, Nfornuh Mungai, James Erupe, Nahashon I Eves, Katie Kimwana, Francis Njoroge Soti, David Akhwale, Willis Hassan, Farah A Juma, Elizabeth Allan, Richard Malar J Research BACKGROUND: Current day malaria cases and deaths are indicative of a lack of access to both methods of prevention, diagnosis, and treatment; an important determinant of treatment efficacy is adherence. This study is a follow up to the baseline study of adherence to artemether-lumefantrine (AL) carried out in Garissa District in 2010. The study presented evaluates any changes in adherence levels which may have occurred in the area during this period and after nearly three years of sustained use of ACT across the public health sector. METHODS: The study was carried out in Garissa County in the North Eastern Province of Kenya and included patients fitting the suspected malaria case definition and having been prescribed AL, regardless of confirmatory diagnosis. A questionnaire assessed the intake of AL via both self-reporting by the participant and observation of blister packs by the interviewer. On separate occasions exit interviews with patients and observations of prescribers were also carried out. RESULTS: Of the 218 participants enrolled, 195 were successfully followed up. 60% of participants were found to be adherent to the three-day AL regimen, this is 4.7% lower than the proportion of participants adherent in 2010; the result of a two-sided z-test was not significant (p = 0.23). The odds of the patient being adherent to AL increased by 65% with each additional correct statement regarding how to take AL that a patient could recall (between zero and four statements), this was the only variable significantly associated with patient adherence (p = 0.01). CONCLUSION: Sustaining the ACT adherence rates at the 2010 levels, through 2.5 years of insecurity in the study area is an achievement and suggests that if security can be improved barriers to improving health service quality and patient adherence to AL would be removed. This study, by looking specifically at anti-malarial adherence over a prolonged period and in a setting of severe conflict, provides a valuable and rare insight in to the challenges and barriers to ACT adherence in such settings. BioMed Central 2015-03-24 /pmc/articles/PMC4405916/ /pubmed/25888895 http://dx.doi.org/10.1186/s12936-015-0645-z Text en © Gore-Langton et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gore-Langton, Georgia R
Alenwi, Nfornuh
Mungai, James
Erupe, Nahashon I
Eves, Katie
Kimwana, Francis Njoroge
Soti, David
Akhwale, Willis
Hassan, Farah A
Juma, Elizabeth
Allan, Richard
Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting
title Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting
title_full Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting
title_fullStr Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting
title_full_unstemmed Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting
title_short Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting
title_sort patient adherence to prescribed artemisinin-based combination therapy in garissa county, kenya, after three years of health care in a conflict setting
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405916/
https://www.ncbi.nlm.nih.gov/pubmed/25888895
http://dx.doi.org/10.1186/s12936-015-0645-z
work_keys_str_mv AT gorelangtongeorgiar patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT alenwinfornuh patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT mungaijames patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT erupenahashoni patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT eveskatie patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT kimwanafrancisnjoroge patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT sotidavid patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT akhwalewillis patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT hassanfaraha patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT jumaelizabeth patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting
AT allanrichard patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting